ViSalus
Vi Prime (30mg)
LNHPD
7314411
Formula hash
e22c4e03811f
Catalog
10
products
With avoid flag
0
products
FDA recalls
0
history
CAERS
2
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| 2,5-Cyclohexadiene-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl other | 30.0 mg | — |
| DL-Alpha Lipoic Acid Alpha Lipoic Acidherb | 150.0 mg | — |
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →